• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Nancy L. Keating, MD, MPH


  • El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L.Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide.Am Soc Clin Oncol Educ Book. 2014;34:e461-6.
  • Freedman RA, Vaz-Luis I, Barry WT, Lii H, Lin NU, Winer EP, Keating NL.Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy.Breast Cancer Res Treat. 2014 Jun(2):491-501.
  • Potosky AL, Haque R, Cassidy-Bushrow AE, Ulcickas Yood M, Jiang M, Tsai HT, Luta G, Keating NL, Smith MR, Van Den Eeden SK.Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer.J Clin Oncol. 2014 May 1;32(13):1324-30.
  • Liu PH, Landrum MB, Weeks JC, Huskamp HA, Kahn KL, He Y, Mack JW, Keating NL.Physicians' Propensity To Discuss Prognosis Is Associated with Patients' Awareness of Prognosis for Metastatic Cancers.J Palliat Med. 2014 Apr 17.
  • Vaz-Luis I, Keating NL, Lin NU, Lii H, Winer EP, Freedman RA.Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study.J Clin Oncol. 2014 Mar 20;32(9):927-34.
  • Wright AA, Zhang B, Keating NL, Weeks JC, Prigerson HG.Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study.BMJ. 2014;348:g1219.
  • Chinn GM, Liu PH, Klabunde CN, Kahn KL, Keating NL.Physicians' preferences for hospice if they were terminally ill and the timing of hospice discussions with their patients.JAMA Intern Med. 2014 Mar;174(3):466-8.
  • Rosario DJ, Bourke L, Keating NL.Androgen deprivation therapy and cardiovascular harm: are all men created equal?.Eur Urol. 2014 Mar;65(3):574-6.
  • Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL.Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia.J Clin Oncol. 2014 Feb 1;32(4):306-11.
  • Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AK, Holmes HM, Jagsi R, Karlekar MB, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Weir AB, Bergman MA, Sundar H.Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .J Natl Compr Canc Netw. 2014 Jan;12(1):82-126.
  • Traeger L, Cannon S, Keating NL, Pirl WF, Lathan C, Martin MY, He Y, Park ER.Race by sex differences in depression symptoms and psychosocial service use among non-Hispanic black and white patients with lung cancer.J Clin Oncol. 2014 Jan 10;32(2):107-13.
  • Taksler GB, Cutler DM, Giovannucci E, Smith MR, Keating NL.Ultraviolet index and racial differences in prostate cancer incidence and mortality.Cancer. 2013 Sep 1;119(17):3195-203.
  • Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ.Incidence of second malignancies among patients treated with proton versus photon radiation.Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):46-52.
  • Freedman RA, Pitcher B, Keating NL, Ballman KV, Mandelblatt J, Kornblith AB, Kimmick GG, Hurria A, Winer EP, Hudis CA, Cohen HJ, Muss HB, .Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.Breast Cancer Res Treat. 2013 Jun;139(2):607-16.
  • Freedman RA, He Y, Winer EP, Keating NL.Racial/Ethnic Differences in Receipt of Timely Adjuvant Therapy for Older Women with Breast Cancer: Are Delays Influenced by the Hospitals Where Patients Obtain Surgical Care?.Health Serv Res. 2013 May 13.
  • Liu PH, Wang JD, Keating NL.Expected years of life lost for six potentially preventable cancers in the United States.Prev Med. 2013 May;56(5):309-13.
  • Conti RM, Dusetzina SB, Herbert AC, Berndt ER, Huskamp HA, Keating NL.The Impact of Emerging Safety and Effectiveness Evidence on the Use of Physician-administered Drugs: The Case of Bevacizumab for Breast Cancer.Med Care. 2013 Apr 17.
  • Pace LE, He Y, Keating NL.Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations.Cancer. 2013 Apr 19.
  • Keating NL, Liu PH, O'Malley AJ, Freedland SJ, Smith MR.Androgen-deprivation Therapy and Diabetes Control Among Diabetic Men with Prostate Cancer.Eur Urol. 2013 Feb 22.
  • Saylor PJ, Smith MR, O'Malley AJ, Keating NL.Androgen-deprivation Therapy and Risk for Biliary Disease in Men with Prostate Cancer.Eur Urol. 2013 Feb 12.
  • Malin JL, Weeks JC, Potosky AL, Hornbrook MC, Keating NL.Medical oncologists' perceptions of financial incentives in cancer care.J Clin Oncol. 2013 Feb 10;31(5):530-5.
  • Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ.Tumor boards and the quality of cancer care.Journal of the National Cancer Institute. 2013 Jan 16;105(2):113-21.
  • Mack JW, Cronin A, Keating NL, Taback N, Huskamp HA, Malin JL, Earle CC, Weeks JC.Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study.J Clin Oncol. 2012 Dec 10;30(35):4387-95.
  • Keating NL, O'Malley A, Freedland SJ, Smith MR.Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.Journal of the National Cancer Institute. 2012 Oct 3;104(19):1518-23.
  • Dusetzina SB, Alexander GC, Freedman RA, Huskamp HA, Keating NL.Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.Breast Cancer Res Treat. 2012 Nov 13.
  • Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D.Patients' expectations about effects of chemotherapy for advanced cancer.N Engl J Med. 2012 Oct 25;367(17):1616-25.
  • Morgans AK, Smith MR, O'Malley AJ, Keating NL.Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy.Cancer. 2012 Oct 12.
  • Freedman RA, Hughes ME, Ottesen RA, Weeks JC, He Y, Wong YN, Theriault R, Keating NL.Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network.Cancer. 2012 Sep 25.
  • Freedman RA, Virgo KS, Labadie J, He Y, Partridge AH, Keating NL.Receipt of locoregional therapy among young women with breast cancer.Breast Cancer Res Treat. 2012 Oct;135(3):893-906.
  • Brooks JM, Chrischilles EA, Landrum MB, Wright KB, Fang G, Winer EP, Keating NL.Survival implications associated with variation in mastectomy rates for early-staged breast cancer.Int J Surg Oncol. 2012;2012:127854.
  • Ligibel JA, O'Malley AJ, Fisher M, Daniel GW, Winer EP, Keating NL.Patterns of bone density evaluation in a community population treated with aromatase inhibitors.Breast Cancer Res Treat. 2012 Aug;134(3):1305-13.
  • Keating NL, Kouri EM, He Y, West DW, Winer EP.Effect of Massachusetts health insurance reform on mammography use and breast cancer stage at diagnosis.Cancer. 2012 Jul 25.
  • McGinty EE, Zhang Y, Guallar E, Ford DE, Steinwachs D, Dixon LB, Keating NL, Daumit GL.Cancer incidence in a sample of Maryland residents with serious mental illness.Psychiatr Serv. 2012 Jul;63(7):714-7.
  • Chatterjee NA, He Y, Keating NL.Racial Differences in Breast Cancer Stage at Diagnosis in the Mammography Era.Am J Public Health. 2012 Jun 14.
  • Klabunde CN, Keating NL, Potosky AL, Ambs A, He Y, Hornbrook MC, Ganz PA.A population-based assessment of specialty physician involvement in cancer clinical trials.Journal of the National Cancer Institute. 2011 Mar 2;103(5):384-97.
  • Saylor PJ, Keating NL, Freedland SJ, Smith MR.Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer.Drugs. 2011 Feb 12;71(3):255-61.
  • Keating NL, O'Malley AJ, Murabito JM, Smith KP, Christakis NA.Minimal social network effects evident in cancer screening behavior.Cancer. 2011 Jan 24.
  • Freedman RA, Virgo KS, He Y, Pavluck AL, Winer EP, Ward EM, Keating NL.The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.Cancer. 2011 Jan 1;117(1):180-9.
  • Keating NL.Medicare reimbursement and prescribing hormone therapy for prostate cancer.Journal of the National Cancer Institute. 2010 Dec 15;102(24):1814-5.
  • Nielsen SS, He Y, Ayanian JZ, Gomez SL, Kahn KL, West DW, Keating NL.Quality of cancer care among foreign-born and US-born patients with lung or colorectal cancer.Cancer. 2010 Dec 1;116(23):5497-506.
  • Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG.Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health.J Clin Oncol. 2010 Oct 10;28(29):4457-64.
  • Keating NL, Beth Landrum M, Arora NK, Malin JL, Ganz PA, van Ryn M, Weeks JC.Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles?.J Clin Oncol. 2010 Oct 1;28(28):4364-70.
  • Keating NL, Landrum MB, Lamont EB, Earle CC, Bozeman SR, McNeil BJ.End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector.Cancer. 2010 Aug 1;116(15):3732-9.
  • Keating NL, Kahn KL.Reply to Physicians and end-of-life issues.Cancer. 2010 May 24.
  • Steinwachs D, Allen JD, Barlow WE, Duncan RP, Egede LE, Friedman LS, Keating NL, Kim P, Lave JR, Laveist TA, Ness RB, Optican RJ, Virnig BA.National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.Ann Intern Med. 2010 May 18;152(10):663-7.
  • Kouri EM, He Y, Winer EP, Keating NL.Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women.Breast Cancer Res Treat. 2010 Jun;121(3):743-51.
  • Rogers SO, Gray SW, Landrum MB, Klabunde CN, Kahn KL, Fletcher RH, Clauser S, Tisnado D, Doucette W, Keating NL.Variations in Surgeon Treatment Recommendations for Lobectomy in Early-Stage Non-Small-Cell Lung Cancer by Patient Age and Comorbidity.Ann Surg Oncol. 2010 Jun;17(6):1581-8.
  • Levine GN, D'Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, Milani RV, Sagalowsky AI, Smith MR, Zakai N, .Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology.CA Cancer J Clin.;60(3):194-201. Review.
  • Keating NL, Landrum MB, Brooks JM, Chrischilles EA, Winer EP, Wright K, Volya R.Outcomes following local therapy for early-stage breast cancer in non-trial populations.Breast Cancer Res Treat. 2010 Apr 8.
  • Earle CC, Chretien Y, Morris C, Ayanian JZ, Keating NL, Polgreen LA, Wallace R, Ganz PA, Weeks JC.Employment Among Survivors of Lung Cancer and Colorectal Cancer.J Clin Oncol. 2010 Apr 1;28(10):1700-5.
  • Oh WK, Landrum MB, Lamont EB, McNeil BJ, Keating NL.Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare?.Urology. 2010 Mar;75(3):642-7.
  • Fang F, Keating NL, Mucci LA, Adami HO, Stampfer MJ, Valdimarsd├│ttir U, Fall K.Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.Journal of the National Cancer Institute. 2010 Mar 3;102(5):307-14.
  • Levine GN, D'Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, Milani RV, Sagalowsky AI, Smith MR, Zakai N, .Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the american heart association, american cancer society, and american urological association: endorsed by the american society for radiation oncology.Circulation. 2010 Feb 16;121(6):833-40.
  • Keating NL, Landrum MB, Rogers SO, Baum SK, Virnig BA, Huskamp HA, Earle CC, Kahn KL.Physician factors associated with discussions about end-of-life care.Cancer. 2010 Feb 15;116(4):998-1006.
  • Allen JD, Barlow WE, Duncan RP, Egede LE, Friedman LS, Keating NL, Kim P, Lave JR, Laveist TA, Ness RB, Optican RJ, Steinwachs D, Virnig BA.NIH State-of-the-Science Conference Statement: Enhancing Use and Quality of Colorectal Cancer Screening.Nih Consensus And State Of The Science Statements. 2010 Feb 4;27(1).
  • Lamont EB, Landrum MB, Keating NL, Archer L, Lan L, Strauss GM, Lilenbaum R, Niell HB, Maurer LH, Kosty MP, Miller AA, Clamon GH, Elias AD, McClay EF, Vokes EE, McNeil BJ.Differences in clinical trial patient attributes and outcomes according to enrollment setting.J Clin Oncol. 2010 Jan 10;28(2):215-21.
  • Keating NL, O'Malley AJ, Freedland SJ, Smith MR.Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.Journal of the National Cancer Institute. 2010 Jan 6;102(1):39-46.
  • Rogers SO, Ayanian JZ, Ko CY, Kahn KL, Zaslavsky AM, Sandler RS, Keating NL.Surgeons' volume of colorectal cancer procedures and collaborative decision-making about adjuvant therapies.Ann Surg. 2009 Dec;250(6):895-900.
  • Saylor PJ, Keating NL, Smith MR.Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.J Gen Intern Med. 2009 Nov;24 Suppl 2:S389-94. Review.
  • Norredam M, Meara E, Landrum MB, Huskamp HA, Keating NL.Financial status, employment, and insurance among older cancer survivors.J Gen Intern Med. 2009 Nov;24 Suppl 2:S438-45.
  • Hu JC, Gu X, Lipsitz SR, Barry MJ, D'Amico AV, Weinberg AC, Keating NL.Comparative effectiveness of minimally invasive vs open radical prostatectomy.JAMA. 2009 Oct 14;302(14):1557-64.
  • Klabunde CN, Ambs A, Keating NL, He Y, Doucette WR, Tisnado D, Clauser S, Kahn KL.The role of primary care physicians in cancer care.J Gen Intern Med. 2009 Sep;24(9):1029-36.
  • Lee IH,Hayman JA,Landrum MB,Tepper J,Tao ML,Goodman KA,Keating NL.Treatment Recommendations for Locally Advanced, Non-Small-Cell Lung Cancer: The Influence of Physician and Patient Factors.Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1376-84.
  • Keating NL, Kouri E, He Y, Weeks JC, Winer EP.Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?.Med Care. 2009 Jul;47(7):765-73.
  • Hassett MJ,O'Malley AJ,Keating NL.Factors influencing changes in employment among women with newly diagnosed breast cancer.Cancer. 2009 Jun 15;115(12):2775-82.
  • Huskamp HA,Keating NL,Malin JL,Zaslavsky AM,Weeks JC,Earle CC,Teno JM,Virnig BA,Kahn KL,He Y,Ayanian JZ.Discussions with physicians about hospice among patients with metastatic lung cancer.Arch Intern Med. 2009 May 25;169(10):954-62.
  • Freedman RA,He Y,Winer EP,Keating NL.Trends in racial and age disparities in definitive local therapy of early-stage breast cancer.J Clin Oncol. 2009 Feb 10;27(5):713-9.
  • Keating NL,Stoeckert KA,Regan MM,DiGianni L,Garber JE.Physicians' experiences with BRCA1/2 testing in community settings.J Clin Oncol. 2008 Dec 10;26(35):5789-96.
  • Keating NL,Zaslavsky AM,Goldstein J,West DW,Ayanian JZ.Randomized trial of $20 versus $50 incentives to increase physician survey response rates.Med Care. 2008 Aug;46(8):878-81.
  • Prasad SM,Keating NL,Wang Q,Pashos CL,Lipsitz S,Richie JP,Hu JC.Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy.Urology. 2008 Sep;72(3):647-52; discussion 652-3.
  • Keating NL, Landrum MB, Klabunde CN, Fletcher RH, Rogers SO, Doucette WR, Tisnado D, Clauser S, Kahn KL.Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?.J Clin Oncol.;26:2532-7.
  • Keating NL,Landrum MB,Klabunde CN,Fletcher RH,Rogers SO,Doucette WR,Tisnado D,Clauser S,Kahn KL.Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?.J Clin Oncol. 2008 May 20;26(15):2532-7.
  • Hu JC, Wang Q, Pashos CL, Lipsitz SR, Keating NL.Utilization and outcomes of minimally invasive radical prostatectomy.J Clin Oncol. 2008 May 10;26(14):2278-84.
  • Smith MR,O'Malley AJ,Keating NL.Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?.BJU Int. 2008 Jun;101(11):1335-6.
  • Keating NL, O'Malley AJ, McNaughton-Collins M, Oh WK, Smith MR.Use of androgen deprivation therapy for metastatic prostate cancer in older men.BJU Int. 2008 May;101(9):1077-83.
  • Landrum MB, Meara ER, Chandra A, Guadagnoli E, Keating NL.Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients.Health Aff (Millwood). 2008 Jan-Feb;27(1):159-68.
  • Rosenthal MB, Landrum MB, Meara E, Huskamp HA, Conti RM, Keating NL.Using performance data to identify preferred hospitals.Health Serv Res. 2007 Dec;42(6 Pt 1):2109-19; discussion 2294-.
  • Stevenson DG, Huskamp HA, Grabowski DC, Keating NL.Differences in hospice care between home and institutional settings.J Palliat Med. 2007 Oct;10(5):1040-7.
  • Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ.Care in the months before death and hospice enrollment among older women with advanced breast cancer.J Gen Intern Med. 2008 Jan;23(1):11-8.
  • Keating NL, Zaslavsky AM, Herrinton LJ, Selby JV, Wolf RE, Ayanian JZ.Quality of diabetes care among cancer survivors with diabetes.Med Care. 2007 Sep;45(9):869-75.
  • Stevenson DG, Huskamp HA, Keating NL, Newhouse JP.Medicare Part D and nursing home residents.J Am Geriatr Soc. 2007 Jul;55(7):1115-25.
  • Keating NL, Landrum MB, Landon BE, Ayanian JZ, Borbas C, Guadagnoli E.The influence of cost containment strategies and physicians' financial arrangements on patients' trust and satisfaction.J Ambul Care Manage. 2007 Apr-Jun;30(2):92-104.
  • Keating NL, Ayanian JZ, Cleary PD, Marsden PV.Factors affecting influential discussions among physicians: a social network analysis of a primary care practice.J Gen Intern Med. 2007 Jun;22(6):794-8.
  • Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ.Surveillance testing among survivors of early-stage breast cancer.J Clin Oncol. 2007 Mar 20;25(9):1074-81.
  • Huskamp HA, Stevenson DG, Donohue JM, Newhouse JP, Keating NL.Coverage and prior authorization of psychotropic drugs under Medicare Part D.Psychiatr Serv. 2007 Mar;58(3):308-10.
  • Grabowski DC, Stevenson DG, Huskamp HA, Keating NL.The influence of Medicare home health payment incentives: does payer source matter?.Inquiry. 2006 Summer;43(2):135-49.
  • Keating NL, O'Malley AJ, Smith MR.Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.J Clin Oncol. 2006 Sep 20;24(27):4448-56.
  • Keating NL, Herrinton LJ, Zaslavsky AM, Liu L, Ayanian JZ.Variations in hospice use among cancer patients.J Natl Cancer Inst. 2006 Aug 2;98(15):1053-9.
  • Keating NL, Landrum MB, Meara E, Ganz PA, Guadagnoli E.Managed care market share and primary treatment for cancer.Health Serv Res. 2006 Feb;41(1):9-22.
  • Keating NL, N°rredam M, Landrum MB, Huskamp HA, Meara E.Physical and mental health status of older long-term cancer survivors.J Am Geriatr Soc. 2005 Dec;53(12):2145-52.
  • Rosenthal MB, Landrum MB, Meara E, Huskamp HA, Conti RM, Keating NL.Using performance data to identify preferred hospitals.Health Serv Res. 2007:in press.
  • Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ.Factors related to underuse of surveillance mammography among breast cancer survivors.J Clin Oncol. 2006 Jan 1;24(1):85-94.
  • Huskamp HA, Keating NL.The new medicare drug benefit: formularies and their potential effects on access to medications.J Gen Intern Med. 2005 Jul;20(7):662-5.
  • Malin JL, Keating NL.The cost-quality trade-off: need for data quality standards for studies that impact clinical practice and health policy.J Clin Oncol. 2005 Jul 20;23(21):4581-4.
  • Keating NL, Landrum MB, Meara E, Ganz PA, Guadagnoli E.Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?.J Natl Cancer Inst. 2005 Feb 16;97(4):257-64.
  • Keating NL, Landrum MB, Ayanian JZ, Winer EP, Guadagnoli E.The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries.J Gen Intern Med. 2005 Jan;20(1):38-44.
  • Persell SD, Keating NL, Landrum MB, Landon BE, Ayanian JZ, Borbas C, Guadagnoli E.Relationship of diabetes-specific knowledge to self-management activities, ambulatory preventive care, and metabolic outcomes.Prev Med. 2004 Oct;39(4):746-52.
  • Keating NL, Landrum MB, Landon BE, Ayanian JZ, Borbas C, Wolf R, Guadagnoli E.The influence of physicians' practice management strategies and financial arrangements on quality of care among patients with diabetes.Med Care. 2004 Sep;42(9):829-39.
  • Keating NL, Gandhi TK, Orav EJ, Bates DW, Ayanian JZ.Patient characteristics and experiences associated with trust in specialist physicians.Arch Intern Med. 2004 May 10;164(9):1015-20.
  • Keating NL, Landon BE, Ayanian JZ, Borbas C, Guadagnoli E.Practice, clinical management, and financial arrangements of practicing generalists.J Gen Intern Med. 2004 May;19(5 Pt 1):410-8.
  • Keating NL, Landrum MB, Landon BE, Ayanian JZ, Borbas C, Guadagnoli E.Measuring the quality of diabetes care using administrative data: is there bias?.Health Serv Res. 2003 Dec;38(6 Pt 1):1529-45.
  • Keating NL, Landrum MB, Ayanian JZ, Winer EP, Guadagnoli E.Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer.J Clin Oncol. 2003 Dec 15;21(24):4532-9.
  • Keating NL, Ayanian JZ.Challenges and opportunities for primary care evaluation.Int J Qual Health Care. 2003 Oct;15(5):371-3.
  • Keating NL, Weeks JC, Borbas C, Guadagnoli E.Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed?.Breast Cancer Res Treat. 2003 May;79(2):225-31.
  • Polsky D, Keating NL, Weeks JC, Schulman KA.Patient choice of breast cancer treatment: impact on health state preferences.Med Care. 2002 Nov;40(11):1068-79.
  • Keating NL, Green DC, Kao AC, Gazmararian JA, Wu VY, Cleary PD.How are patients' specific ambulatory care experiences related to trust, satisfaction, and considering changing physicians?.J Gen Intern Med. 2002 Jan;17(1):29-39.
  • Keating NL, Guadagnoli E, Landrum MB, Borbas C, Weeks JC.Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement?.J Clin Oncol. 2002 Mar 15;20(6):1473-9.
  • Keating NL, Weeks JC, Landrum MB, Borbas C, Guadagnoli E.Discussion of treatment options for early-stage breast cancer: effect of provider specialty on type of surgery and satisfaction.Med Care. 2001 Jul;39(7):681-91.
  • Dudley RA, Landon BE, Rubin HR, Keating NL, Medlin CA, Luft HS.Assessing the relationship between quality of care and the characteristics of health care organizations.Med Care Res Rev. 2000;57 Suppl 2:116-35.
  • Keating NL, Zaslavsky AM, Ayanian JZ.Physicians' reports of focused expertise in clinical practice.J Gen Intern Med. 2000 Jun;15(6):417-20.
  • Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ.Use of hormone replacement therapy by postmenopausal women in the United States.Ann Intern Med. 1999 Apr 6;130(7):545-53.
  • Keating NL, Zaslavsky AM, Ayanian JZ.Physicians' experiences and beliefs regarding informal consultation.JAMA. 1998 Sep 9;280(10):900-4.